154 related articles for article (PubMed ID: 19148465)
1. Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck.
Kimura M; Kato Y; Sano D; Fujita K; Sakakibara A; Kondo N; Mikami Y; Tsukuda M
Int J Oncol; 2009 Feb; 34(2):321-7. PubMed ID: 19148465
[TBL] [Abstract][Full Text] [Related]
2. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
3. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
4. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
Yavrouian EJ; Sinha UK; Rice DH; Salam MT; Gill PS; Masood R
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):985-91. PubMed ID: 18794445
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
6. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
Masood R; Kumar SR; Sinha UK; Crowe DL; Krasnoperov V; Reddy RK; Zozulya S; Singh J; Xia G; Broek D; Schönthal AH; Gill PS
Int J Cancer; 2006 Sep; 119(6):1236-48. PubMed ID: 16615113
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
van Herpen CM; Bussink J; van der Kogel AJ; Peeters WJ; van der Voort R; van Schijndel A; de Wilde PC; Adema GJ; de Mulder PH
Anticancer Res; 2005; 25(2A):1015-21. PubMed ID: 15868941
[TBL] [Abstract][Full Text] [Related]
8. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.
Thomas SM; Zeng Q; Epperly MW; Gooding WE; Pastan I; Wang QC; Greenberger J; Grandis JR
Clin Cancer Res; 2004 Oct; 10(20):7079-87. PubMed ID: 15501988
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants.
Vosseler S; Mirancea N; Bohlen P; Mueller MM; Fusenig NE
Cancer Res; 2005 Feb; 65(4):1294-305. PubMed ID: 15735015
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.
Van Aarsen LA; Leone DR; Ho S; Dolinski BM; McCoon PE; LePage DJ; Kelly R; Heaney G; Rayhorn P; Reid C; Simon KJ; Horan GS; Tao N; Gardner HA; Skelly MM; Gown AM; Thomas GJ; Weinreb PH; Fawell SE; Violette SM
Cancer Res; 2008 Jan; 68(2):561-70. PubMed ID: 18199553
[TBL] [Abstract][Full Text] [Related]
13. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
Erber R; Eichelsbacher U; Powajbo V; Korn T; Djonov V; Lin J; Hammes HP; Grobholz R; Ullrich A; Vajkoczy P
EMBO J; 2006 Feb; 25(3):628-41. PubMed ID: 16424904
[TBL] [Abstract][Full Text] [Related]
14. Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31.
Korff T; Dandekar G; Pfaff D; Füller T; Goettsch W; Morawietz H; Schaffner F; Augustin HG
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):468-74. PubMed ID: 16357318
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ephrinB2 leads to increased angiogenesis in ischemic myocardium and endothelial cell proliferation.
Månsson-Broberg A; Siddiqui AJ; Genander M; Grinnemo KH; Hao X; Andersson AB; Wärdell E; Sylvén C; Corbascio M
Biochem Biophys Res Commun; 2008 Aug; 373(3):355-9. PubMed ID: 18571496
[TBL] [Abstract][Full Text] [Related]
16. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
18. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
[TBL] [Abstract][Full Text] [Related]
19. Stromal cells modulate ephrinB2 expression and transmigration of hematopoietic cells.
Okubo T; Yanai N; Obinata M
Exp Hematol; 2006 Mar; 34(3):330-8. PubMed ID: 16543067
[TBL] [Abstract][Full Text] [Related]
20. Downmodulation of bFGF-binding protein expression following restoration of p53 function.
Sherif ZA; Nakai S; Pirollo KF; Rait A; Chang EH
Cancer Gene Ther; 2001 Oct; 8(10):771-82. PubMed ID: 11687900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
